Quality of Life Data in CheckMate 274: Does It Move the Needle?

Affiliations

¹ Centro de Câncer de Brasilia, Instituto Unity de Ensino e Pesquisa, Brasilia, DF, Brazil.
² Department of Medical Oncology, City of Hope Orange County Medical Center, Irvine, CA, USA.
³ Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: spal@coh.org.

Editorial

Cristiane Decat Bergerot et al. Eur Urol Oncol. 2022 Oct.

. 2022 Oct;5(5):564-565.

doi: 10.1016/j.euo.2022.03.008. Epub 2022 Apr 26.

¹ Centro de Câncer de Brasilia, Instituto Unity de Ensino e Pesquisa, Brasilia, DF, Brazil.
² Department of Medical Oncology, City of Hope Orange County Medical Center, Irvine, CA, USA.
³ Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: spal@coh.org.

No abstract available

Comment on

Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial.
Witjes JA, Galsky MD, Gschwend JE, Broughton E, Braverman J, Nasroulah F, Maira-Arce M, Ye X, Shi L, Guo S, Hamilton M, Bajorin DF. Witjes JA, et al. Eur Urol Oncol. 2022 Oct;5(5):553-563. doi: 10.1016/j.euo.2022.02.003. Epub 2022 Mar 11. Eur Urol Oncol. 2022. PMID: 35288066 Free PMC article. Clinical Trial.